Kairos Pharma’s Bhowmick presents at Discovery on Target drug discovery conference
Bitget2026/09/23 12:00- Kairos Pharma will participate in the Discovery on Target Drug Discovery Conference in Boston from Sept. 28 to Oct. 1.
- Neil Bhowmick will moderate an in-person breakout, “Winning the Race against Cancer Therapy Resistance,” on Sept. 30.
- Bhowmick will deliver a Sept. 30 main-stage presentation on KROS-101, a GITR-targeting candidate for solid tumors.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Silver Price Forecast: XAG/USD trades flat around $53 ahead of US inflation data
Swiss Franc holds ground as US Dollar consolidates ahead of CPI inflation data
Net profit surges fivefold but masks decline in core business; crypto mining companies' shift to AI poses hidden risks
Marathon Holdings' Q3 net profit reached $632 million, up 413% year-on-year. However, its mining revenue declined by 35%. The company relied on selling 13,500 BTC to pay off debts and is now betting on AI infrastructure, increasing the risk of an imbalanced profit structure.
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Crypto prices
More
